Skip to main content

HH&L Acquisition Co. (HHLA-UN)

New York Stock Exchange Financial Services Shell CompaniesView data quality →
45.4Fair

ValueMarkers Composite Index

Top 14%#38,395 of 44,707

DCF data not available

Piotroski
2/9
Weak
Beneish
-
Altman
7.45
Safe
DCF Value
-
N/A
ROIC
-1.1%
Low
P/E
14.0
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

HH&L Acquisition Co. (HHLA-UN) — VMCI valuation read

Headline read on HHLA-UN: VMCI of 45/100 versus a Financial Services sector median of 50. The 5-point below-median position is what makes HH&L Acquisition Co. a relative-value laggard in the mid-cap cohort, before any pillar-level review.

Form 4 filings on HHLA-UN: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.

**Investor frame.** Three reads on HHLA-UN: value (HHLA-UN trades at 19.0x earnings, 6% above the Financial Services median of 18.0x), quality (ROIC of 19.0% sits 9.0pp above the Financial Services median (10.0%)), and risk (net debt to EBITDA of -2.0x leaves covenant headroom). The value read also implies an EV/EBITDA gap of +4.0x against the Financial Services 12.0x baseline.

HHLA-UN rose 3.4% over the trailing 7 days, with a -14.5% read on a 30-day basis.

HH&L Acquisition Co. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on healthcare or healthcare-related companies in Asian markets. The company was incorporated in 2020 and is based in Central, Hong Kong.

CEO: Qi LiHKwww.hopuhl.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in HHLA-UN’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.